SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The meme coin $CAW, also known as crow with knife, is trending as the community buzzes about its multichain presence across Solana, BSC, CRO, and ETH, plus its deflationary mechanism. Community members highlight its organic growth and partnerships, while also mentioning staking opportunities may be coming.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses potential catalysts and its broader ecosystem. Conversations highlight the emergence of new meme coins built on Solana, like $SOLYCAT and $CAW, while others focus on staking opportunities. There is also bullish sentiment around its long-term potential and increasing institutional interest as Fidelity now offers Solana.

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is trending as a new Solana-based meme token, generating buzz around its recent launch and availability on Phantom Wallet. The community is drawn to its potential for high gains, with many emphasizing its momentum within the Solana ecosystem alongside established tokens. Conversations highlight its strong chart and potential breakout.

An AI x Metaverse Protocol that is building the future of virtual interactions.

Virtual Protocol

Virtual Protocol is trending as the community discusses its recent price action and potential. Some traders are pointing to listing on Robinhood as a catalyst, while others debate whether it's a pump and dump, but many bulls see strong potential due to the project's focus on AI and development of AI agents. Discussion includes the ecosystem utility and agents like G.A.M.E, which are gaining traction.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin is trending as the community debates its potential to break key resistance levels amid general market volatility, with some expressing frustration over its price action relative to Bitcoin and Binance Coin. There's also buzz around the coin's association with memecoins and upcoming catalysts like potential ETF approval and new partnerships for the Cronos chain. Community members are weighing the potential impact of these developments on CRO's price.

USDC is a fully collateralized US dollar stablecoin. USDC is the bridge between dollars and trading on cryptocurrency exchanges. The technology behind CENTRE makes it possible to exchange value between people, businesses and financial institutions just like email between mail services and texts between SMS providers. We believe by removing artificial economic borders, we can create a more inclusive global economy.

USD Coin

USD Coin is trending as discussions swirl around stablecoin regulation and its potential role in the evolving financial landscape. Community members are weighing in on its stability, integration with various platforms like Solana, and comparisons to other stablecoins like USDT.  Additionally, its adoption in decentralized finance (DeFi) and real-world applications, like cross-border payments and tokenized assets, are being closely monitored.

Ambarella, Inc. engages in the development of low-power system-on-a-chip, or SoC, semiconductors and software for edge artificial intelligence, or AI, applications. Its products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. The firm's geographical segments include Taiwan, Asia Pacific, Europe, North America other than United States and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella is trending after surprising investors with strong guidance and Q2 results, driven by AI-powered edge processing. Community members are actively discussing the company's potential for growth in the drone, automotive, and robotics sectors, along with speculation regarding a potential buyout. Some traders are also pointing to the stock's technical setup and low float, suggesting it could be primed for further upside.

WISeKey International Holding Ltd. is a cybersecurity company, which engages in offering digital security technology solutions. The firm operates through the Internet of Things (IoT), and Managed Public Key Infrastructure (mPKI) segments. The IoT segment refers to the design, manufacturing, sales and distribution of microprocessors operations. The mPKI segment includes all operations relating to the provision of secured access keys, authentication, signing software, certificates and digital security applications. The company was founded by Joao Carlos Creus Moreira and Philippe Doubre in 1999 and is headquartered in Zug, Switzerland.

WISeKey International Holding Ltd - ADR

WISeKey is trending as investors discuss its potential upside in the post-quantum computing era, particularly in securing satellite constellations. The community is highlighting the company's subsidiaries, including SEALCOIN and WISeSat, and comparing its market cap to its parent company, LAES.  Some investors believe WKEY's current valuation doesn't reflect the value of its assets and potential growth in the quantum security market.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending as the community discusses the company's recent acquisition of Astria Therapeutics, a move aimed at strengthening its position in the hereditary angioedema (HAE) market. While some investors express concerns about potential dilution and debt, others view the acquisition as a strategic move to capture a larger share of the HAE market by offering both oral and injectable treatments. The community is actively debating the long-term benefits and risks associated with this expansion strategy within the competitive biotech landscape.

Pump.fun

$PUMP is trending as traders discuss its strong community and potential within the Solana ecosystem, with many mentioning $WAGMI and highlighting the token's resilience. Community members are emphasizing holding for the long term and believe the project is coded for success. The conversation includes discussion of potential catalysts and continued building within the $SOL ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Adma Biologics (ADMA) Fell More Than Broader Market

Adma Biologics (ADMA) closed at $14.56 in the latest trading session, marking a -3.51% move from the prior day.

Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?

The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Adma Biologics (ADMA) Stock Moves -1.36%: What You Should Know

In the latest trading session, Adma Biologics (ADMA) closed at $14.54, marking a -1.36% move from the previous day.

Why Adma Biologics (ADMA) Outpaced the Stock Market Today

Adma Biologics (ADMA) concluded the recent trading session at $15.05, signifying a +2.66% move from its prior day's close.

Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?

Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors

In the latest trading session, Adma Biologics (ADMA) closed at $15.32, marking a -2.17% move from the previous day.

Are Options Traders Betting on a Big Move in ADMA Biologics Stock?

Investors need to pay close attention to ADMA stock based on the movements in the options market lately.

Adma Biologics (ADMA) Stock Dips While Market Gains: Key Facts

In the latest trading session, Adma Biologics (ADMA) closed at $15.91, marking a -1.55% move from the previous day.

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note

Adma Biologics (ADMA) closed the most recent trading day at $15.3, moving 5.03% from the previous trading session.

Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?

Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

ADMA
Adma Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADMA News

ADMAAdma Biologics Inc